Khunpradit Suthit, Lumbiganon Pisake, Laopaiboon Malinee
Department of Obstetrics and Gynaecology, Lamphun Hospital, 177 Jamthevee Road, Lamphun, Lamphun, Thailand, 51000.
Cochrane Database Syst Rev. 2011 Jun 15;2011(6):CD008410. doi: 10.1002/14651858.CD008410.pub2.
Evidence on the benefits of admission tests other than cardiotocography in preventing adverse perinatal outcomes has not been established.
To assess the effectiveness of admission tests other than cardiotocography in preventing adverse perinatal outcomes.
We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (31 March 2011).
Randomised (individual and cluster) controlled trials, comparing labour admission tests other than CTG for the prevention of adverse perinatal outcomes.
Two review authors independently assessed eligibility, quality and extracted data.
We included one study involving 883 women.Comparison of sonographic assessment of amniotic fluid index (AFI) on admission versus no sonographic assessment of AFI on admission. The incidence of cesarean section for fetal distress in the intervention group (29 of 447) was significantly higher than those of controls (14 of 436) (risk ratio (RR) 2.02; 95% confidence interval (CI) 1.08 to 3.77).The incidence of Apgar score less than seven at five minutes in the intervention group (10 of 447) was not significantly different from controls (seven of 436) (RR 1.39, 95% CI 0.54 to 3.63).The incidence of artificial oxytocin for augmentation of labour in the intervention group (213 of 447) was significantly higher than controls (132 of 436) (RR 1.57; 95% CI 1.32 to 1.87).The incidence of neonatal NICU admission in the intervention group (35 of 447) was not significantly different from the controls (33 of 436) (RR 1.03; 95% CI 0.66 to 1.63)
AUTHORS' CONCLUSIONS: There is not enough evidence to support the use of admission tests other than cardiotocography for fetal assessment during labour. Appropriate randomised controlled trials with adequate sample size of admission tests other than cardiotocography for fetal assessment during labour are required.
除胎心监护外,关于入院检查在预防围产期不良结局方面的益处尚无证据。
评估除胎心监护外的入院检查在预防围产期不良结局方面的有效性。
我们检索了Cochrane妊娠与分娩组试验注册库(2011年3月31日)。
随机(个体和整群)对照试验,比较除CTG外的分娩入院检查对预防围产期不良结局的作用。
两位综述作者独立评估研究的合格性、质量并提取数据。
我们纳入了一项涉及883名女性的研究。比较入院时羊水指数(AFI)的超声评估与未进行AFI超声评估。干预组因胎儿窘迫行剖宫产的发生率(447例中的29例)显著高于对照组(436例中的14例)(风险比(RR)2.)。干预组5分钟时阿氏评分低于7分的发生率(447例中的10例)与对照组(436例中的7例)无显著差异(RR 1.39,95%置信区间(CI)0.54至3.63)。干预组使用人工缩宫素加强宫缩的发生率(447例中的213例)显著高于对照组(436例中的132例)(RR 1.57;95%CI 1.32至1.87)。干预组新生儿入住新生儿重症监护病房的发生率(447例中的35例)与对照组(436例中的33例)无显著差异(RR 1.03;95%CI 0.66至1.63)
没有足够证据支持在分娩期间使用除胎心监护外的入院检查进行胎儿评估。需要进行适当的随机对照试验,纳入足够样本量的除胎心监护外的分娩入院胎儿评估检查。